The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
124954336 12495433 6 F 20141120 20160829 20160624 20160906 EXP PHHY2009CA075052 NOVARTIS 71.33 YR F Y 0.00000 20160906 OT CA CA

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
124954336 12495433 1 PS SANDOSTATIN LAR DEPOT OCTREOTIDE ACETATE 1 Intramuscular 30 MG, QMO Y 21008 30 MG VIAL /month
124954336 12495433 2 SS SANDOSTATIN LAR DEPOT OCTREOTIDE ACETATE 1 Intramuscular 30 MG, EVERY 02 WEEKS Y 21008 30 MG VIAL QOW
124954336 12495433 3 SS SANDOSTATIN LAR DEPOT OCTREOTIDE ACETATE 1 Intramuscular 20 MG, EVERY 02 WEEKS Y 21008 20 MG VIAL QOW
124954336 12495433 4 SS SANDOSTATIN LAR DEPOT OCTREOTIDE ACETATE 1 Intramuscular 30 MG, BIW Y 21008 30 MG VIAL QOW
124954336 12495433 5 SS SANDOSTATIN LAR DEPOT OCTREOTIDE ACETATE 1 Intramuscular 30 MG, QMO Y 21008 30 MG VIAL /month
124954336 12495433 6 SS SANDOSTATIN LAR DEPOT OCTREOTIDE ACETATE 1 Intramuscular 30 MG, BIW Y 21008 30 MG VIAL QOW
124954336 12495433 7 SS SANDOSTATIN LAR DEPOT OCTREOTIDE ACETATE 1 Intramuscular 30 MG, QMO Y 21008 30 MG VIAL /month
124954336 12495433 8 SS SANDOSTATIN LAR DEPOT OCTREOTIDE ACETATE 1 Intramuscular 30 MG, EVERY 03 WEEKS Y 21008 30 MG VIAL Q3W
124954336 12495433 9 SS SANDOSTATIN LAR DEPOT OCTREOTIDE ACETATE 1 Intramuscular 30 MG, QMO Y 21008 30 MG VIAL /month
124954336 12495433 10 SS SANDOSTATIN LAR DEPOT OCTREOTIDE ACETATE 1 Intramuscular 30 MG, BIW (EVERY 2 WEEKS) Y S00089, S0090, S0092 21008 30 MG VIAL QOW
124954336 12495433 11 SS SANDOSTATIN LAR DEPOT OCTREOTIDE ACETATE 1 Intramuscular 30 MG, BIW (EVERY 2 WEEKS) Y 21008 30 MG VIAL QOW
124954336 12495433 12 SS AFINITOR EVEROLIMUS 1 Oral 2.5 MG, QD 0 2.5 MG QD
124954336 12495433 13 SS AFINITOR EVEROLIMUS 1 Oral 10 MG, QD 0 10 MG QD
124954336 12495433 14 SS AFINITOR EVEROLIMUS 1 Oral 5 MG, QD 0 5 MG QD
124954336 12495433 15 SS AFINITOR EVEROLIMUS 1 Oral 7.5 MG, QD 0 7.5 MG QD
124954336 12495433 16 C SYNTHROID LEVOTHYROXINE SODIUM 1 Unknown U 0
124954336 12495433 17 C LIPITOR ATORVASTATIN CALCIUM 1 Unknown 40 MG, QD U 0 40 MG QD
124954336 12495433 18 C LYRICA PREGABALIN 1 Unknown U 0
124954336 12495433 19 C PANTOLOC//PANTOPRAZOLE SODIUM SESQUIHYDRATE PANTOPRAZOLE SODIUM 1 Unknown 40 MG, QD U 0 40 MG QD
124954336 12495433 20 C CARBOCAL D CALCIUMVITAMIN D 1 Unknown 500 MG, BID U 0 500 MG BID
124954336 12495433 21 C MIRTAZAPINE. MIRTAZAPINE 1 Unknown 15 MG, QHS U 0 15 MG
124954336 12495433 22 C CLONAZEPAM. CLONAZEPAM 1 Unknown 0.5 MG, QHS U 0 .5 MG
124954336 12495433 23 C NOVO-ATENOL 2 Unknown 25 MG U 0 25 MG
124954336 12495433 24 C NORVASC AMLODIPINE BESYLATE 1 Unknown 2.5 MG, QD U 0 2.5 MG QD
124954336 12495433 25 C NOVO-ALENDRONATE ALENDRONIC ACID 1 Unknown 1 DF, QW U 0 1 DF INJECTION /wk
124954336 12495433 26 C RATIO-MORPHINE 2 Unknown 15 MG, BID U 0 15 MG BID
124954336 12495433 27 C PREGABALINE PREGABALIN 1 Unknown 0
124954336 12495433 28 C PANTOLOC ^BYK GULDEN^ 2 Unknown 40 MG, QD U 0 40 MG QD

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
124954336 12495433 1 Neuroendocrine tumour
124954336 12495433 12 Neuroendocrine tumour
124954336 12495433 16 Product used for unknown indication
124954336 12495433 17 Product used for unknown indication
124954336 12495433 18 Product used for unknown indication
124954336 12495433 19 Product used for unknown indication
124954336 12495433 20 Product used for unknown indication
124954336 12495433 21 Product used for unknown indication
124954336 12495433 22 Product used for unknown indication
124954336 12495433 23 Product used for unknown indication
124954336 12495433 24 Product used for unknown indication
124954336 12495433 25 Product used for unknown indication
124954336 12495433 26 Product used for unknown indication
124954336 12495433 27 Product used for unknown indication
124954336 12495433 28 Product used for unknown indication

Outcome of event

Event ID CASEID OUTC COD
124954336 12495433 HO
124954336 12495433 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
124954336 12495433 Abdominal pain
124954336 12495433 Abdominal pain lower
124954336 12495433 Abdominal pain upper
124954336 12495433 Anaemia
124954336 12495433 Anal incontinence
124954336 12495433 Anorectal discomfort
124954336 12495433 Anxiety
124954336 12495433 Application site bruise
124954336 12495433 Asthenia
124954336 12495433 Back pain
124954336 12495433 Balance disorder
124954336 12495433 Bladder pain
124954336 12495433 Blood calcium decreased
124954336 12495433 Blood glucose increased
124954336 12495433 Blood iron decreased
124954336 12495433 Blood magnesium decreased
124954336 12495433 Blood pressure decreased
124954336 12495433 Blood pressure increased
124954336 12495433 Blood pressure systolic increased
124954336 12495433 Bone decalcification
124954336 12495433 Burning sensation
124954336 12495433 Chills
124954336 12495433 Chromosome analysis abnormal
124954336 12495433 Decreased appetite
124954336 12495433 Dehydration
124954336 12495433 Depressed mood
124954336 12495433 Depression
124954336 12495433 Diarrhoea
124954336 12495433 Dizziness
124954336 12495433 Dyspepsia
124954336 12495433 Dyspnoea exertional
124954336 12495433 Dysstasia
124954336 12495433 Faeces discoloured
124954336 12495433 Faeces pale
124954336 12495433 Fatigue
124954336 12495433 Feeling hot
124954336 12495433 Flatulence
124954336 12495433 Fluid retention
124954336 12495433 Flushing
124954336 12495433 Gastrointestinal neoplasm
124954336 12495433 Haematochezia
124954336 12495433 Haemoglobin decreased
124954336 12495433 Haemorrhoids
124954336 12495433 Headache
124954336 12495433 Heart rate decreased
124954336 12495433 Hot flush
124954336 12495433 Hypercholesterolaemia
124954336 12495433 Hyperphagia
124954336 12495433 Hypersomnia
124954336 12495433 Hypertension
124954336 12495433 Inappropriate schedule of drug administration
124954336 12495433 Incorrect product storage
124954336 12495433 Injection site mass
124954336 12495433 Injection site pain
124954336 12495433 Injection site reaction
124954336 12495433 Injury
124954336 12495433 Insomnia
124954336 12495433 Intestinal haemorrhage
124954336 12495433 Joint swelling
124954336 12495433 Lung neoplasm
124954336 12495433 Malaise
124954336 12495433 Malignant neoplasm progression
124954336 12495433 Metastases to abdominal cavity
124954336 12495433 Metastases to gastrointestinal tract
124954336 12495433 Metastases to liver
124954336 12495433 Metastases to lung
124954336 12495433 Metastases to lymph nodes
124954336 12495433 Metastases to oesophagus
124954336 12495433 Metastases to pancreas
124954336 12495433 Metastases to peritoneum
124954336 12495433 Mouth haemorrhage
124954336 12495433 Mouth swelling
124954336 12495433 Mouth ulceration
124954336 12495433 Musculoskeletal pain
124954336 12495433 Nausea
124954336 12495433 Needle issue
124954336 12495433 Nocturia
124954336 12495433 Nodule
124954336 12495433 Ocular hyperaemia
124954336 12495433 Oral administration complication
124954336 12495433 Pain
124954336 12495433 Pain in extremity
124954336 12495433 Paraesthesia
124954336 12495433 Pollakiuria
124954336 12495433 Proctalgia
124954336 12495433 Product quality issue
124954336 12495433 Renal mass
124954336 12495433 Renal pain
124954336 12495433 Skin discolouration
124954336 12495433 Stomach mass
124954336 12495433 Tremor
124954336 12495433 Underdose
124954336 12495433 Urinary tract infection
124954336 12495433 Varicose vein
124954336 12495433 Visual impairment
124954336 12495433 Weight decreased

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
124954336 12495433 1 20090721 0
124954336 12495433 4 20110920 0
124954336 12495433 7 20131112 0
124954336 12495433 10 20141229 0
124954336 12495433 12 201409 0

Execution Time: 0.0092239379882812 seconds (ucode:5222880). Developed by: James D. Barger

 


another James Barger innovation
All original content on this site is © 2013-2024 James D. Barger and SafetyRates.com.